simulations plus, inc. (nasdaq: slp) is the premier developer of modeling & simulation software and consulting services supporting drug discovery, development research and regulatory submissions. we partner with companies to provide a data-driven, ‘strateg

Simulations Plus, Inc.

New position in SLP

This member is verified by the Commonstock team based on their contributions to the Commonstock community. 

Verified Member

This member connected a brokerage account and is sharing trades and portfolio performance with the community. 

Public Portfolio

Josh Kohn-Lindquist

Sold 50% of SLP

Camden Jones

Sold 63% of SLP

Sold all SLP

Steven

Bought 8% more SLP

Bought 30% more SLP

JP Coviello

Bought 100% more SLP

Traded SLP

Andrew Cameron